Commission Regulation (EEC) No 3769/92 of 21 December 1992 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances
Modified by
Commission Regulation (EEC) No 2959/93of 27 October 1993amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substancesCorrigendum to Commission Regulation (EEC) No 2959/93 of 27 October 1993 amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances(Official Journal of the European Communities No L 267 of 28 October 1993), 31993R295931993R2959R(01), October 28, 1993
Commission Regulation (EC) No 2093/97of 24 October 1997amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances, 31997R2093, October 25, 1997
Commission Regulation (EC) No 1610/2000of 24 July 2000amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances, 32000R1610, July 25, 2000
Commission Regulation (EC) No 1251/2001of 26 June 2001amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances, 32001R1251, June 27, 2001
Commission Regulation (EC) No 1232/2002of 9 July 2002replacing the Annex to Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances and amending Regulation (EEC) No 3769/92, 32002R1232, July 10, 2002
Commission Regulation (EC) No 1277/2005of 27 July 2005laying down implementing rules for Regulation (EC) No 273/2004 of the European Parliament and of the Council on drug precursors and for Council Regulation (EC) No 111/2005 laying down rules for the monitoring of trade between the Community and third countries in drug precursors(Text with EEA relevance), 32005R1277, August 3, 2005
Corrected by
Corrigendum to Commission Regulation (EEC) No 2959/93 of 27 October 1993 amending Regulation (EEC) No 3769/92 implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substances, 31993R2959R(01), January 5, 1994
Commission Regulation (EEC) No 3769/92of 21 December 1992implementing and amending Council Regulation (EEC) No 3677/90 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substancesTHE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Economic Community,Having regard to Council Regulation (EEC) No 3677/90 of 13 December 1990 laying down measures to be taken to discourage the diversion of certain substances to the illicit manufacture of narcotic drugs and psychotropic substancesOJ No L 357, 20. 12. 1990, p. 1., as amended by Regulation (EEC) No 900/92OJ No L 96, 10. 4. 1992, p. 1., and in particular Article 10 (3) thereof,Whereas it is necessary to lay down implementing rules for Regulation (EEC) No 3677/90, hereinafter referred to as "the basic Regulation";Whereas the threshold quantities of the scheduled substances listed in Category 3 of the Annex to the basic Regulation and the identification of mixtures containing such substances should be defined for the purpose of Article 2a (2) of the basic Regulation;Whereas it is necessary to identify the countries and substances pursuant to Article 5 (2) of the basic Regulation, in particular, on the basis of a concerted approach with the country concerned;Whereas, in certain cases, when there is no formal agreement with the destination country within the meaning of Article 5a (2) of the basic Regulation, the export requirements for scheduled substances in Category 3 must be identified, in particular, on the basis of a concerted approach with the country concerned;Whereas the identification of sensitive destinations has to take place on the basis that a country is concerned, either by the illicit manufacture of narcotic drugs and psychotropic substances or by other relevant factors such as geographical proximity to a country in which such drugs or substances are produced;Whereas the Commission undertakes to establish such contacts with a number of countries; the lists in Annexes 2 and 3 to this Regulation should therefore be gradually supplemented to the extent that such contacts lead to concrete results;Whereas it is necessary to design a model of the individual export authorization as well as detailed rules concerning its use and furthermore to establish such rules for implementing the open individual authorization scheme provided for in relation to certain exports of Category 2 and 3 substances;Whereas the Community should implement the decision taken by the Commission on Narcotic Drugs (CND) of the United Nations in April 1992 to include the substances safrole, piperonal and isosafrole in Table I of the Annex to the 1988 UN Convention against illicit traffic in narcotic drugs and psychotropic substances, by transferring the said substances from Category 2 to Category 1 in the Annex to the basic Regulation and for reasons of clarity the Annex to the basic Regulation should therefore be replaced; the decision was based on the grounds that the characteristics of the said substances are very similar to those already contained in Table I as well as those in Category 1 of the Final Report of the Chemical Action Task Force (CATF), and the CATF members represented in the CND have fully shared the decision as an exceptional measure relating to international trade which would provide no precedent as to other possible divergences with regard to the classification under the CATF report;Whereas the measures provided for in this Regulation are in accordance with the opinion of the Drugs Precursors Committee,HAS ADOPTED THIS REGULATION: